Tempus AI Inc header image

Tempus AI Inc

TEM

Equity

ISIN null / Valor 135855934

NASDAQ (2026-09-22)
USD 77.19-1.08%

Tempus AI Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Tempus AI Inc., founded in August 2015 by Eric Lefkofsky, is a technology company specializing in the application of artificial intelligence to cancer care. The company aims to harness real-time healthcare data to personalize diagnostics and treatment plans for cancer patients. With the recruitment of its first employee, Ryan Fukushima, Tempus has focused on developing a robust platform that integrates and analyzes vast amounts of clinical and molecular data. This platform is designed to provide actionable insights to healthcare providers, thereby improving patient outcomes through more precise and tailored treatment strategies.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-10.1%1Y
%3Y
%5Y

Performance

70.4%1Y
96.3%3Y
96.3%5Y

Volatility

Market cap

13538 M

Market cap (USD)

Daily traded volume (Shares)

5,998,167

Daily traded volume (Shares)

1 day high/low

34.57 / 32.97

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Winston Hu
UK, 03 Nov 2025
star star star star star
High potential within this stock

EQUITIES OF THE SAME SECTOR

Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.55%INR 850.35
TransMedics Group Inc
TransMedics Group Inc TransMedics Group Inc Valor: 47361695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.89%USD 88.07
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.19%CHF 364.10
Johnson & Johnson
Johnson & Johnson Johnson & Johnson Valor: 943981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%USD 269.19
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.73%CHF 97.86
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.34%CHF 83.50
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.21%CHF 218.40
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd Max Healthcare Institute Ltd Valor: 45624817
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.90%INR 1,064.50
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.48%INR 594.70
Gland Pharma Ltd.
Gland Pharma Ltd. Gland Pharma Ltd. Valor: 56038514
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.68%INR 2,941.65